Since poly(GR) expression in patient brains with C9ORF72 mutations correlates with neurodegeneration and clinical phenotypes9–11, we examined whether poly(GR) levels in CSF samples of patients with C9ORF72-related ALS and ALS/FTD correlate with clinical features. The gene discussed is C9orf72; the disease is frontotemporal dementia.